September 30, 2020
LMG Life Sciences named the firm’s win in Mayne Pharma v. Merck Sharpe & Dohme as a Patent Impact Case of the Year. LMG Life Sciences announced the award at its annual awards presentation on September 23, 2020.
Gibson Dunn’s Intellectual Property Practice Group offers strategic insights and solutions to companies facing complex intellectual property issues. We have a deep bench of trial lawyers with technical backgrounds, advanced degrees and industry experience provides the necessary insight to develop and defend against sophisticated claims in a wide range of industries and complex technologies. Our litigators are recognized throughout the industry as leaders in prosecuting, defending and trying IP claims in federal and state courts, before administrative bodies including the U.S. International Trade Commission and U.S. Patent and Trademark Office (USPTO), as well as before arbitration panels.